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A B S T R A C T
Background
This is an update of a Cochrane review first published in The Cochrane Library in Issue 2, 2002 and previously updated in 2004, 2007
and 2010.
Radiotherapy, open surgery and endolaryngeal excision (with or without laser) are all accepted modalities of treatment for early-stage
glottic cancer. Case series suggest that they confer a similar survival advantage, however radiotherapy and endolaryngeal surgery offer
the advantage of voice preservation. There has been an observed trend away from open surgery in recent years, however equipoise
remains between radiotherapy and endolaryngeal surgery as both treatment modalities offer laryngeal preservation with similar survival
rates. Opinions on optimal therapy vary across disciplines and between countries.
Objectives
To compare the effectiveness of open surgery, endolaryngeal excision (with or without laser) and radiotherapy in the management of
early glottic laryngeal cancer.
Search methods
We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register; the Cochrane Central Register of Controlled Trials
(CENTRAL 2014, Issue 8); PubMed; EMBASE; CINAHL; Web of Science; Cambridge Scientific Abstracts; ICTRP and additional
sources for published and unpublished trials. The date of the most recent search was 18 September 2014.
Selection criteria
Randomised controlled trials comparing open surgery, endolaryngeal resection (with or without laser) and radiotherapy.
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Data collection and analysis
We used the standard methodological procedures expected by The Cochrane Collaboration.
Main results
We identified only one randomised controlled trial, which compared open surgery and radiotherapy in 234 patients with early glottic
laryngeal cancer. The overall risk of bias in this study was high.
For T1 tumours, the five-year survival was 91.7% following radiotherapy and 100% following surgery and for T2 tumours, 88.8%
following radiotherapy and 97.4% following surgery. There were no significant differences in survival between the two groups.
For T1 tumours, the five-year disease-free survival rate was 71.1% following radiotherapy and 100.0% following surgery, and for the
T2 tumours, 60.1% following radiotherapy and 78.7% following surgery. Only the latter comparison was statistically significant (P
value = 0.036), but statistical significance would not have been achieved with a two-sided test.
Data were not available on side effects, quality of life, voice outcomes or cost.
We identified no randomised controlled trials that included endolaryngeal surgery. A number of trials comparing endolaryngeal resection
and radiotherapy have terminated early because of difficulty recruiting participants. One randomised controlled trial is still ongoing.
Authors’ conclusions
There is only one randomised controlled trial comparing open surgery and radiotherapy but its interpretation is limited because of
concerns about the adequacy of treatment regimens and deficiencies in the reporting of the study design and analysis.
P L A I N L A N G U A G E S U M M A R Y
Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early larynx cancer
Background
Cancer of the larynx or voice box usually begins in the glottis (vocal cords) as a squamous cell cancer (cancer in the membranes). Most
people survive these cancers when they get treatment early, before the cancer spreads further into the larynx and surrounding area.
Options include radiotherapy, open surgery where access is through the neck or, more commonly now, endolaryngeal excision whereby
the throat is reached through the mouth, sometimes with a laser.
Study characteristics
This review of trials identified just one trial including 234 patients with early glottic cancer, which compared radiotherapy to open
surgery. This was a multicentre randomised controlled trial undertaken in the former Soviet Union, Hungary and Czechoslovakia.
Patients were followed up for five years and recurrence-free and survival rates were measured.
Key results
The results of this trial showed that there was no significant difference in survival between patients treated with radiotherapy or open
surgery.
Further data from trials comparing radiotherapy and endolaryngeal surgery are needed to determine the best way of treating early
laryngeal cancer, however a number of studies have been abandoned because of difficulties in recruiting participants. One trial is still
ongoing.
We found that there is not enough evidence to show which form of treatment might be better for people with early-stage larynx cancer.
Quality of the evidence
The included study is of low quality. The evidence in this review is up to date to September 2014.
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B A C K G R O U N D
This is an update of a Cochrane review first published in The
Cochrane Library in Issue 2, 2002 and previously updated in 2004,
2007 and 2010.
Description of the condition
Over 150,000newcases of laryngeal cancer are diagnosed each year
(GLOBOCAN 2012); the highest rates are observed in Southern
and Eastern Europe (Parkin 1997).Men aremore likely to develop
laryngeal cancer than women. Smoking and alcohol are proven
risk factors and the temporal decline in incidence of this cancer in
some populations is consistent with a decline in the consumption
of tobacco (Coleman 1993).
Laryngeal cancers most commonly arise from the glottis, i.e. the
true vocal cord, and are usually squamous cell carcinomas. Three-
quarters of these patients present early, i.e. without vocal cord fixa-
tion, nodal involvement or extension beyond the larynx (Groome
2001; Joslin 1995; Robin 1989; Shah 1997). Reported five-year
survival rates following treatment of these early tumours, adjusted
for deaths from other causes, frequently exceed 85% (Groome
2001; Joslin 1995; Robin 1989; Shah 1997).
Description of the intervention
Radiotherapy, open surgery and endolaryngeal excision are all ac-
cepted modalities of treatment for early-stage glottic cancer (T1-
T2, N0). Radiotherapy utilises ionising radiation to initiate dou-
ble-stranded breaks of nuclear DNA leading to loss of the cells’
reproductive ability and eventually to cell death. Radiotherapy of-
fers laryngeal preservation, however it is a prolonged treatment
course and may be associated with unpleasant adverse effects in-
cluding oral mucositis, dysphagia, radiation skin burns and xe-
rostomia. Open laryngeal surgery involves an open neck wound
with partial or total surgical resection of the larynx with insertion
of an indwelling voice prosthesis to allow speech in cases of total
laryngectomy, although total laryngectomy is rarely indicated for
early-stage cancers. Endolaryngeal surgery is minimally invasive
in comparison and involves resection of the tumour via the tran-
soral route with or without the use of laser, with the advantages of
preservation of voice and laryngeal function.
Why it is important to do this review
When this review was originally written in 2002, early laryn-
geal tumours were largely treated with open surgery or radio-
therapy, with results of case series demonstrating similar survival
rates. Radiotherapy offers the advantage of voice preservation over
open surgery, therefore it was previously the generally preferred
treatmentmodality (Groome 2001;Mendenhall 1994;O’Sullivan
1994; Shah 1997; Stalpers 1989). However, open surgery re-
mained an option, particularly in populations without access to
specialist centres for radiotherapy.
In recent years endolaryngeal surgery (with or without laser) has
grown in popularity (DAHNO 2012), and there has been an ob-
served trend away from open surgery as a result. Endolaryngeal
surgery offers survival rates that are similar to radiotherapy and
has an advantage over open surgery in preservation of voice and
laryngeal function. A number of systematic reviews of non-ran-
domised studies have been undertaken (Abdurehim 2011; Feng
2011; Higgins 2009; Spielmann 2010), all of which have failed to
demonstrate a significant difference between survival rates after ra-
diotherapy or endolaryngeal surgery. Voice outcomes may also be
similar following radiotherapy and endolaryngeal surgery (Cohen
2006;Hirano 1985; Keilmann 1996;McGuirt 1994; Sittel 1998),
thus creating a position of equipoise between these two treatment
modalities.
Endolaryngeal resection requires access to specialist surgeons with
appropriate experience and expertise, however recent years have
seen an apparent increase in the use of this modality of treatment
(Hoffman 2006). For example, in England and Wales it has been
reported that patients are as likely to receive transoral laser-assisted
microsurgical resection as they are to receive radiotherapy (Bradley
2009; DAHNO 2012), although there remains a geographical
discrepancy as some UK centres still do not offer transoral laser
surgery (DAHNO 2012).
If recurrence does occur, the options for further treatment after en-
dolaryngeal surgery not only include open surgery but also further
endolaryngeal resection and radiotherapy, whereas locoregional
failure after radiotherapy can only be treated with major open sur-
gical intervention (Goh 1996; Jensen 1994; Smee 2000). Addi-
tionally, as endolaryngeal resection is often a day-case procedure,
some clinicians believe that treatment costs will be less than for
radiotherapy (Brandenburg 2001; Goor 2007); this is supported
by a recent cost-utility analysis (Higgins 2011).
Therapeutic conflicts in the management of early laryngeal can-
cers are sustained by the belief that randomised controlled trials
have not been and could not be undertaken (Goh 1996). We have
undertaken a systematic review to identify any randomised con-
trolled trials comparing open surgery, radiotherapy and endola-
ryngeal excision in patients with early glottic cancer.
O B J E C T I V E S
To compare the effectiveness of open surgery, endolaryngeal exci-
sion (with or without laser) and radiotherapy in the management
of early glottic laryngeal cancer.
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M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials that compared open
surgery, endolaryngeal resection and/or radiotherapy. We did not
consider trials which compared different radiotherapeutic tech-
niques. We also excluded trials which were primarily a compari-
son of treatments for advanced laryngeal cancer.We only included
trials with a radiotherapy arm when patients were predominantly
recruited from 1980 onwards, because of concerns that regimens
prior to that date may have been sub-optimal.
Types of participants
The study population was limited to patients diagnosed with early
squamous cell carcinoma of the glottic larynx following laryn-
goscopy and biopsy. Early-stage tumours were defined as carci-
noma in situ (Tis) or invasive cancers confined to the vocal cords
or with supraglottic or subglottic extension without cord fixation
or nodal metastases (T1-T2, N0) (Sobin 1997).
Types of interventions
Open surgery, endolaryngeal excision (with or without laser) and/
or radiotherapy.
Types of outcome measures
Primary outcomes
Wecompareddifferentmodalities of treatment using the following
primary outcome measure:
• Mortality - survival at five years.
Secondary outcomes
• Morbidity - post-treatment complications (bleeding,
mucositis, swallowing dysfunction, weight loss), immediate and
delayed.
• Voice quality - at one year.
• Recurrence of disease - at five years.
• Quality of life - at one year.
• Cost.
Search methods for identification of studies
We conducted systematic searches for randomised controlled tri-
als. There were no language, publication year or publication status
restrictions. The date of the most recent search was 18 September
2014, following previous searches in November 2013, February
2013, 2012, 2009, 2007, 2006, 2003 and 2000.
Electronic searches
We searched the following databases from their inception for pub-
lished, unpublished and ongoing trials: the Cochrane Ear, Nose
and Throat Disorders Group Trials Register; the Cochrane Cen-
tral Register of Controlled Trials (CENTRAL 2014, Issue 8);
PubMed; EMBASE; CINAHL; LILACS; KoreaMed; IndMed;
PakMediNet; CAB Abstracts; Web of Science; ClinicalTrials.gov;
ICTRP; Google Scholar and Google. In searches prior to 2013,
we also searched BIOSIS Previews 1926 to 2012, ISRCTN and
CNKI.
We modelled subject strategies for databases on the search strat-
egy designed for CENTRAL. Where appropriate, we combined
subject strategies with adaptations of the highly sensitive search
strategy designed by The Cochrane Collaboration for identify-
ing randomised controlled trials and controlled clinical trials (as
described in theCochrane Handbook for Systematic Reviews of In-
terventions Version 5.1.0, Box 6.4.b. (Handbook 2011)). Search
strategies for major databases including CENTRAL are provided
in Appendix 1.
Searching other resources
We scanned the reference lists of retrieved review articles to iden-
tify other trials and wrote to a number of researchers who had
published in this area. We handsearched the Proceedings of the
2nd World Congress on Laryngeal Cancer and the 5th Interna-
tional Conference for Head and Neck Cancer for abstracts of, and
references to, other relevant studies.
Data collection and analysis
Selection of studies
One author performed the searches and two authors reviewed the
abstracts. We requested and translated manuscripts of potentially
relevant studies whenever necessary. LauraWarner (LW) and Paola
Dey (PD) reviewed relevantmanuscripts to identify reports of ran-
domised controlled trials comparing the interventions of interest
in patients with early-stage laryngeal cancer. When randomised
controlled trials were identified we obscured information which
could identify the journal of publication, authors’ names and their
affiliation before the manuscripts were independently assessed by
two further authors (Kenneth McKenzie (KMacK) and Richard
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Wight (RW)) to determine eligibility for inclusion in the review
and methodological quality.
Data extraction and management
Two authors used a data extraction form adapted from the pro-
forma designed by the Cochrane Musculoskeletal Injuries Group
to extract data and assess risk of bias. PD contacted the authors of
the included trial for additional information.
Assessment of risk of bias in included studies
LW and PD undertook assessment of the risk of bias of the in-
cluded trials independently, with the following taken into consid-
eration, as guided by theCochrane Handbook for Systematic Reviews
of Interventions (Handbook 2011):
• sequence generation;
• allocation concealment;
• blinding;
• incomplete outcome data;
• selective outcome reporting; and
• other sources of bias.
We used the Cochrane ’Risk of bias’ tool in RevMan 5.3 (RevMan
2014), which involves describing each of these domains as reported
in the trial and then assigning a judgement about the adequacy of
each entry: ’low’, ’high’ or ’unclear’ risk of bias. We reported these
judgements in a ’Risk of bias’ table.
Data synthesis
If there are sufficient data available from trials of comparable in-
terventions and outcomes in future updates of this review, we will
pool data in a meta-analysis for each outcome for the following
comparisons:
• radiotherapy with surgery;
• surgery with transoral laser surgery;
• radiotherapy with transoral laser surgery.
Wewill assess statistical heterogeneity using the I2 statistic.Wewill
use Peto odds ratios with 95% confidence intervals to summarise
five-year overall and disease-free survival and other dichotomous
variables. We will use standardised mean differences (SMD) when
pooling continuous data from comparable measures. If data are
available, we may undertake subgroup analysis for different tu-
mour stages.
R E S U L T S
Description of studies
Results of the search
The most recent update search in September 2014 identified 450
records, the previous search in November 2013 identified 469
records and the search in February 2013 identified 1010 records,
however no new published randomised controlled trials were iden-
tified (Figure 1). In the 2014 update, we also confirmed that
one study remains ongoing (Saedi 2007) (see Characteristics of
ongoing studies). Other trials which we had previously identified
as ongoing have either now been abandoned (Abdurehim 2009;
EaStER 2006), or there was no response from the authors when
contacted (Coman 2003). The EaStER feasibility randomised trial
comparing the effectiveness of radiotherapy and endoscopic exci-
sion (with or without laser) is closed and recruited only 17 patients
to the trial, however the patients were reported as being followed
up, so the status is unknown (EaStER 2006) (see Characteristics
of studies awaiting classification).
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Figure 1. Study flow diagram.
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A total of 962 abstracts had been reviewed following the update
searches covering the period 2000 to October 2009. The original
searches for the review identified 455 abstracts. From the com-
bined searches we identified four possible randomised controlled
trials comparing surgery and radiotherapy. We excluded three of
these, with reasons (Hintz 1979; Li 1993; Yin 2000), and we in-
cluded one trial in the review (Ogoltsova 1990). We identified no
randomised controlled trials including endolaryngeal surgery.
Included studies
See Characteristics of included studies.
Only one trial recruited a substantial number of patients with
glottic cancer; this was a multicentre randomised controlled trial
undertaken in Eastern Europe, that is the former Soviet Union,
Hungary and Czechoslovakia (Ogoltsova 1990). Patients were re-
cruited from 1979 and randomised to open surgery, radiotherapy
or a combination of radiotherapy and chemotherapy after stratifi-
cation by anatomical site (glottis or supraglottis) and tumour stage
(T1 or T2). Two hundred and sixty-nine patients were evaluated,
of whom 234 had glottic laryngeal cancer. Patients were followed
up for five years and recurrence-free and survival rates were re-
ported.
Excluded studies
See Characteristics of excluded studies.
Hintz et al reported the results of a randomised controlled trial
involving 108 head and neck patients. We excluded this trial be-
cause of the small number of eligible patients who were recruited
between 1971 and 1976. Seventy-five patients were available for
analysis of whom only 24 had early stage glottic cancer; staging
was retrospective. Patients were not stratified by site or stage be-
fore randomisation and of eight patients with T2 glottic cancer
only one received surgery. Analysis was not on an intention-to-
treat basis. The authors suggest that radiotherapy dosimetry may
have been sub-optimal (Hintz 1979).
We excluded one trial immediately after translation; this ran-
domised controlled trial reported on the efficacy of preoperative
radiotherapy and only 14 patients with early glottic laryngeal can-
cer were randomised to surgery alone (Li 1993).
We excluded a further trial because it assessed the effectiveness of
postoperative radiotherapy, and the stage of disease was not clearly
defined (Yin 2000).
Abdurehim 2009, which we had previously identified as an on-
going study, has now been abandoned due to difficulty recruiting
patients.
Risk of bias in included studies
We had a number of concerns about the methodology of the in-
cluded study (Ogoltsova 1990), and we originally gave it a ’grade
C’ quality rating. At the 2014 update, using the Cochrane ’Risk
of bias’ tool, we judged it to be at high risk of bias.
Allocation
Randomisation was by consecutive numbers, which were imple-
mented in each co-operative centre by “converters”, but it is not
clear whether the randomisation schedule was concealed from the
investigators. The total number of patients randomised to each
treatment arm is not provided and data are not available on the
baseline characteristics of treatment groups at study entry. The
number of patients evaluated in each group is unbalanced; 76
were allocated surgery but 129 allocated radiotherapy. A further
64 evaluable patients were allocated combination therapy, that
is radiotherapy and chemotherapy; these patients are not further
considered in this review. There is no evidence that the trial was
designed with 2:1 allocation, but the authors do admit that follow-
up was poor and therefore the imbalance may be due to differen-
tial follow-up.
Blinding
Outcomes were not assessed blind and no detail is provided on
how and when outcome assessment was performed.
Incomplete outcome data
There were difficulties with the completion of follow-up and loss
of patients to follow-up during the study is mentioned.
Selective reporting
The number of patients with glottic cancer evaluated in each arm
is not provided. The number of patients in each arm available for
outcome evaluation at specified time points is not available.
Other potential sources of bias
The method of diagnosis and preoperative staging is not detailed,
but the investigators suggest that patients had been inadequately
staged before treatment. The authors were concerned that surgical
interventions had not been standardised and that radiotherapy
regimensmay be sub-optimal; patients received gamma irradiation
suggesting the use of cobalt units and neither treatment volume
nor technique are reported.
Survival is compared using a Mantel-Haenszel test and the Chi²
statistic at 1 degree of freedom is reported at the one-sided 5%
significance level.
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Effects of interventions
One study is included in the review (Ogoltsova 1990).
Primary outcome
Mortality - survival at five years
Five-year survival rates are presented for each tumour stage (T1
and T2) for patients with glottic cancer. The number of events and
the number of patients at risk in each arm at each specified time
point are not presented. For T1 tumours, the five-year survival
was 91.7% following radiotherapy and 100% following surgery
and for T2 tumours, 88.8% following radiotherapy and 97.4%
following surgery. There were no significant differences in survival
between the two groups.
Secondary outcomes
Morbidity - post-treatment complications (bleeding,
mucositis, swallowing dysfunction, weight loss), immediate
and delayed
No data were available for this outcome.
Voice quality - at one year
No data were available for this outcome.
Recurrence of disease - at five years
Five-year locoregional recurrence rates are presented for each tu-
mour stage for patients with glottic cancer. Again the number of
events and the number of patients at risk in each arm at each spec-
ified time point are not presented. There is some inconsistency
in the text regarding the number of locoregional recurrences in
the whole group. For T1 tumours, the five-year disease-free sur-
vival rate was 71.1% following radiotherapy and 100.0% follow-
ing surgery, and for the T2 tumours, 60.1% following radiother-
apy and 78.7% following surgery. Only the latter comparison is
statistically significant (Chi 1.8, P value = 0.036), but statistical
significance would not have been achieved with a two-sided test.
Quality of life - at one year
No data were available for this outcome.
Cost
No data were available for this outcome.
D I S C U S S I O N
Summary of main results
There is no good evidence available from randomised controlled
trials to guide treatment choice for patients with early-stage glottic
cancer.
Quality of the evidence
Interpretation of the findings of the only randomised controlled
trial that recruited substantial numbers of patients to a compar-
ison between radiotherapy and open surgery is limited by con-
cerns about the adequacy of treatment regimens and deficiencies
in the reporting of the study design and analysis. In this trial, open
surgical outcomes were better than might be expected from data
derived from case series whilst radiotherapy outcomes were worse.
The trial investigators admitted that patients were inadequately
staged prior to therapy, and radiotherapy may have been sub-op-
timal. In addition, follow-up was poor and differences between
groups may be biased by differential follow-up.
There are no published randomised controlled trials comparing
the effectiveness of endolaryngeal resection with either radiother-
apy or open surgery and difficulties in recruiting and randomising
patients with early laryngeal cancers has been noted by authors of
abandoned studies. The difficulties in recruiting to the EaStER
trial are addressed in a paper by Hamilton et al, who describe a
difference in surgeons’ and recruiters’ opinions of optimum treat-
ment of carcinoma in situ and those tumours involving the an-
terior commissure. Additionally, the recruiters felt that there was
non-equivalence of the treatment process as endolaryngeal surgery
was often considered by patients and clinicians to be more con-
venient compared to radiotherapy and therefore consent to ran-
domisation was not given (Hamilton 2013).
Potential biases in the review process
At the 2014 update, using the Cochrane ’Risk of bias’ method,
we judged the included study to be at high risk of bias (Ogoltsova
1990).
Agreements and disagreements with other
studies or reviews
Our recent search has identified five systematic reviews comparing
endolaryngeal surgery and radiotherapy published since 2009 (
Abdurehim 2011; Feng 2011; Higgins 2009; Spielmann 2010;
Yoo 2013). None identified any randomised trials and they varied
in staging criteria, types of study (comparative only or case series
and comparative studies) and outcomes for study inclusion. Those
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including comparative studies only suggest similar oncological and
functional outcomes (Abdurehim 2011; Feng 2011; Spielmann
2010; Yoo 2013).
Several studies have reported use of concomitant chemoradiother-
apy in the treatment of T2 laryngeal cancers (Niibe 2007; Ohguri
2008). The results show promising local control rates, particularly
when combined with debulking transoral laser surgery. In years to
come concomitant chemoradiotherapy may gain popularity as it
offers organ preservation with improved local control rates. The
efficacy of this new approach will need to be further elucidated.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Based on the results of one randomised controlled trial, there re-
mains uncertainty as to the comparative benefits and societal costs
of different treatment modalities for patients with early glottic
laryngeal cancer. Using the Cochrane ’Risk of bias’ method we
judged this study to have a high risk of bias.
Endolaryngeal surgery is gaining popularity in the management
of early laryngeal tumours due to voice preservation, shorter treat-
ment duration and results from case series, which show similar
survival rates to radiotherapy (Csanady 1995; Eckel 2001;Mahieu
2000;Mendenhall 2004;Motta 1997; Ossoff 1985; Steiner 1993;
Wolfensberger 1990; Zeitels 1996). Like radiotherapy, endolaryn-
geal resection is voice-sparing and the shorter treatment duration
may further benefit patients and lead to resource savings. In West-
ern countries, where open surgery is infrequently performed, en-
dolaryngeal resection is becoming more popular. A consensus doc-
ument on behalf of the ENT-UKHead and Neck Group reported
that endoscopic excision is now generally the preferred treatment
option, particularly for T1a tumours, and suggested that endola-
ryngeal surgery should be offered to all patients with early la-
ryngeal tumours up to stage 2a (Bradley 2009). As experience
with endolaryngeal surgery increases, the application of this treat-
ment modality is expanding to involve more extensive laryngeal
tumours, although radiotherapy may offer preferable vocal out-
comes when extensive cordectomy is required (Silver 2009). Fur-
thermore, treatment of the anterior commissure remains contro-
versial as local recurrence rates and vocal outcomes after transoral
laser assisted surgery are worse when the anterior commissure is
involved and radiotherapy is therefore often preferred in this sub-
set of patients (Chone 2007; Hakeem 2013; Sachse 2009).
Implications for research
Most patients diagnosed with early laryngeal cancer in Western
countries are now treated with either radiotherapy or endolaryn-
geal surgery. A number of workers consider that it is unlikely that
randomised controlled trials comparing open surgery and radio-
therapy can be undertaken, because somany clinicians believe that
the three treatment modalities confer similar survival advantage
but that voice outcomes after open surgery are worse. However,
the continuedpublicationof non-randomised studies suggests that
even in the West there remains some controversy as to the most
cost-effective treatment (Groome 2001). This systematic review
demonstrates that a randomised controlled trial comparing radio-
therapy and open surgery has been undertaken (Ogoltsova 1990),
however its conclusions are compromised by methodological and
analytical deficiencies.
We identified two recent trials and two protocols for studies. The
EaStER feasibility randomised trial (EaStER 2006), comparing
the effectiveness of radiotherapy and endoscopic excision (with or
without laser), is closed and recruited only 17 patients. The status
of the other randomised controlled trial that recruited participants
is unknown (Coman 2003). One randomised trial was abandoned
due to difficulty in recruiting patients (Abdurehim 2009), and one
further study is ongoing (Saedi 2007).
A paper by Hamilton et al details the specific difficulties in re-
cruiting patients to the EaStER trial (Hamilton 2013). The au-
thors describe how surgeons and recruiters felt there was a lack
of equipoise between the two treatment options, as endolaryngeal
surgery was considered to be more convenient, meaning that re-
cruitment discussions focused on the treatment process rather than
expected outcomes. Furthermore, whilst endolaryngeal surgery is
generally preferred for T1a cancers, particularly mid-cord lesions,
radiotherapy is preferred for anterior commissure lesions, thus the
anatomical location of the tumour may create bias when consid-
ering recruiting patients to a trial.
Although difficulties have been encountered in recruiting patients
to randomised controlled trials, it remains vitally important that
randomised studies are undertaken in this field. As data from
non-randomised series have demonstrated similar oncological out-
comes between radiotherapy and endolaryngeal surgery, quality of
life and vocal outcome data must be studied.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Ogoltsova 1990
Methods Randomised controlled trial
Participants 234 patients with T1 or T2 glottic carcinoma
Interventions Open surgery versus radiotherapy
Outcomes Disease-free survival
Overall survival
Notes Method of concealment of allocation unclear
Total number of patients randomised and total number randomised to each groupunclear
No comparison of baseline characteristics at entry
Radiotherapy regimens might be considered sub-optimal
Numbers of patients at risk and number of events at specified time points not stated
Inconsistencies between text and tables
Statistical tests quoted at the one-sided 5% level but this is not explicit in the text
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk The total number of patients randomised to each treat-
ment arm is not provided and data are not available on
the baseline characteristics of treatment groups at study
entry. The number of patients evaluated in each group is
unbalanced
Allocation concealment (selection bias) Unclear risk Randomisation was by consecutive number generation,
however it is not stated whether clinicians were blinded
to this process. The numbers treated in each group were
unbalanced and the total initially randomised to each
group is not stated. Baseline characteristics between the
2 groups are not provided
Blinding (performance bias and detection
bias)
All outcomes
High risk Blinding of treatments was not possible in this study due
to the nature of treatments
Incomplete outcome data (attrition bias)
All outcomes
High risk Difficulties completing follow-up and loss of patients to
follow-up during the study is mentioned
Selective reporting (reporting bias) Unclear risk The number of patients with glottic cancer evaluated in
each arm is not provided. The number of patients in each
arm available for outcome evaluation at specified time
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Ogoltsova 1990 (Continued)
points is not available
Other bias High risk The investigators suggest that patients may have been
inadequately staged before treatment. Surgical interven-
tions were not standardised and the radiotherapy regi-
mens may be sub-optimal, with neither treatment vol-
ume nor technique stated
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Abdurehim 2009 Study abandoned due to difficulty recruiting patients
Hintz 1979 ALLOCATION:
Random, concealed, not stratified by site
PARTICIPANTS:
Patients diagnosed with squamous carcinoma of any head and neck site between 1971 and 1976. Only 24 patients
had early glottic cancer; 7 T2 cancers allocated radiotherapy and one allocated surgery
INTERVENTIONS:
Radiotherapy and surgery. Radiotherapy regimen may be sub-optimal
OUTCOME MEASURES:
Local control rates, voice function. Analysis not on an intention-to-treat basis
Li 1993 ALLOCATION:
Stratified randomisation, concealment unclear
PARTICIPANTS:
Patients diagnosed with laryngeal cancer (all histological and clinical types and stage). Only 25 patients had early
glottic cancer
INTERVENTIONS:
Preoperative radiotherapy and surgery compared with surgery alone. 14 patients with early glottic laryngeal cancer
randomised to surgery alone
OUTCOME MEASURES:
3- and 5-year survival; postoperative infection rate
Yin 2000 (Information derived from conference proceedings abstract only)
ALLOCATION:
Following surgery, method unclear, concealment unclear
PARTICIPANTS:
92 patients; stage unclear
INTERVENTIONS:
Surgery and postoperative radiotherapy compared with surgery alone
OUTCOME MEASURES:
3- and 5-year survival
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Characteristics of studies awaiting assessment [ordered by study ID]
Coman 2003
Methods Randomised controlled trial
Participants Patients with T1 or T2 N0 M0 glottic cancer
Interventions Laser surgery using CO2 laser
Radiotherapy (EBRT 60 to 66 Gy for 5 days a week over 6 to 6.5 weeks)
Outcomes Primary outcomes:
Local control
Voice quality
Swallowing function
Quality of life
Nutrition
Cost of treatment
Secondary outcomes:
Degree of larynx preservation
Loco-regional control
Disease-specific survival rate
Quantitative and qualitative evaluation of toxicity aspects of treatment
Notes Not able to establish recent contact with principal investigator to determine current status of trial
EaStER 2006
Methods Randomised controlled trial
Participants Patients with Tis, Tis T1 T2a N0 M0 carcinoma of the glottis
Interventions Endoscopic excision: cold steel or laser
Radiotherapy: Tis T1 non bulky tumours 50 Gy
T1 bulky T2a 55 Gy
Outcomes Primary outcome:
Loco-regional recurrence
Secondary outcomes:
Voice quality
Quality of life
Morbidity
Mortality
Economic assessment
Notes This study is closed and recruited only 17 patients to the trial, however the patients were reported as being followed
up, so the status is unknown. It is said that this study has shown that endoscopic excision is the preferred treatment
option (Bradley 2009).
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Characteristics of ongoing studies [ordered by study ID]
Saedi 2007
Trial name or title The comparison of voice quality in early laryngeal cancer between surgery and radiotherapy
Methods Randomised, controlled, single-blind study
Participants Patients with early laryngeal cancer
Interventions Partial laryngectomy versus radiotherapy
Outcomes Voice quality at 3 to 6 months
Quality of life at 6 months
Starting date March 2007
Contact information Professor Babak Saedi, Imam Khomainee Hospital, Tehran, Iran
E-mail: saedi@tums.ac.ir
Notes Published results were expected in 2013 but have not yet been published
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D A T A A N D A N A L Y S E S
This review has no analyses.
A P P E N D I C E S
Appendix 1. Search strategies
CENTRAL PubMed EMBASE (Ovid)
#1MeSHdescriptorNeoplasms explode all
trees
#2 cancer* OR malignan* OR premalig-
nan* OR neoplasm OR carcinoma* OR
dysplasiaOR tumor*OR tumour*ORpre-
cancer*
#3 (#1 OR #2)
#4 MeSH descriptor Larynx explode all
trees
#5MeSHdescriptor LaryngealDiseases ex-
plode all trees
#6 laryn* OR vocal cord* OR cordal OR
glott* OR throat OR voice box OR sub-
glotti* OR supraglotti*
#7 (#4 OR #5 OR #6)
#8 (#3 AND #7)
#9 MeSH descriptor Laryngeal Neoplasms
explode all trees
#10 (#8 OR #9)
#11 MeSH descriptor Radiotherapy ex-
plode all trees
#12 irradiat*:ti OR radiotherap*:ti OR ra-
diation:ti
#13 MeSH descriptor Surgical Procedures,
Operative explode all trees
#14 MeSH descriptor Otorhinolaryngo-
logic Surgical Procedures explode all trees
#15 MeSH descriptor Microsurgery ex-
plode all trees
#16 MeSH descriptor Surgical Procedures,
Minimally Invasive explode all trees
#17 MeSH descriptor Laser Therapy ex-
plode all trees
#18 surgery:ti OR surgical*:ti OR laryn*:
ti NEAR preserve*:ti OR laryngectom*:
ti OR hemilaryngectom*:ti OR excision
#1 “Neoplasms” [Mesh]OR (cancer* [tiab]
OR malignan* [tiab] OR premalignan*
[tiab]ORneoplasm* [tiab]ORcarcinoma*
[tiab]ORdysplasia [tiab]OR tumor* [tiab]
OR tumour* [tiab] OR precancer* [tiab]
#2 “Larynx” [Mesh] OR “LARYNGEAL
DISEASES” [Mesh] OR laryn* [tiab] OR
“vocal cord*” [tiab] OR cordal [tiab] OR
glott* [tiab] OR throat [tiab] OR “voice
box” [tiab] OR subglotti* [tiab] OR supra-
glotti* [tiab]
#3 #2 AND #1
#4 “LARYNGEAL NEOPLASMS”
[Mesh]
#5 #4 OR #3
#6 “Radiotherapy” [Mesh] OR irradiat*
[tiab] OR radiotherap* [tiab] OR radiation
[tiab]
#7 “SURGICAL PROCEDURES OP-
ERATIVE” [Mesh] OR “OTORHINO-
LARYNGOLOGIC SURGICAL PRO-
CEDURES” [Mesh] OR “Microsurgery”
[Mesh]
OR “SURGICAL PROCEDURES MIN-
IMALLY INVASIVE” [Mesh] OR “laser
surgery” [Mesh]
#8 surgery [tiab] OR surgical* [tiab] OR
(laryn* [tiab] AND preserv* [tiab]) OR la-
ryngectom* [tiab] OR hemilaryngectom*
[tiab] OR “excision biops*” [tiab] OR en-
doscop* [tiab]ORendolaryngeal [tiab]OR
transoral* [tiab] OR “trans oral*” [tiab]
OR (neck [tiab] AND incision* [tiab]) OR
cordectom* [tiab] OR (vocal [tiab] AND
cord [tiab] AND stripping [tiab])
1 exp neoplasm/
2 (cancer* or malignan* or premalignan*
or neoplasm* or carcinoma* or dysplasia or
tumor* or tumour* or precancer*).ti.
3 exp larynx/
4 (laryn* or (vocal adj cord*) or cordal or
glott* or throat or (voice adj box) or sub-
glotti* or supraglotti*).ti.
5 exp larynx disorder/
6 1 or 2
7 4 or 3 or 5
8 6 and 7
9 exp larynx tumor/
10 8 or 9
11 exp radiotherapy/
12 (irradiat* or radiotherap* or radiation).
ti.
13 exp surgery/ or exp EAR NOSE
THROAT SURGERY/ or exp Larynx
surgery/ or dissection/ or exp endoscopic
surgery/ or exp laser surgery/ or exp micro-
surgery/ or exp excision/
14 (surgery or surgical* or (laryn* and pre-
serv*) or laryngectom* or hemilaryngec-
tom* or “excision biops*” or endoscop* or
endolaryngeal or transoral* or “trans oral*”
or (neck and incision*) or cordectom* or
(vocal and cord and stripping)).ti.
15 11 or 13 or 12 or 14
16 10 and 15
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(Continued)
biops*:ti OR endoscop*:ti OR endolaryn-
geal:ti OR transoral*:ti OR trans:ti NEXT
oral*:ti OR neck:ti NEAR incision:ti OR
cordectom*:ti OR vocal:ti NEXT cord:ti
NEXT stripping:ti
#19 (#11 OR #12 OR #13 OR #14 OR #
15 OR #16 OR #17 OR #18)
#20 (#10 AND #19)
#9 #7 OR #8 OR #6
#10 #5 AND #9
Web of Science CINAHL (EBSCO) ICTRP
#1 TI=(cancer* or malignan* or premalig-
nan* or neoplasm* or carcinoma* or dys-
plasia or tumor* or tumour* or precancer*)
#2 TI=(laryn* or (vocal adj cord*) or cordal
or glott* or throat or (voice adj box) or sub-
glotti* or supraglotti*)
#3 TI=(irradiat* or radiotherap* or radia-
tion)
#4 TI=(surgery or surgical* or (laryn* and
preserv*) or laryngectom* or hemilaryngec-
tom* or “excision biops*” or endoscop* or
endolaryngeal or transoral* or “trans oral*”
or (neck and incision*) or cordectom* or
(vocal and cord and stripping))
#5 #2 AND #1
#6 #4 OR #3
#7 #6 AND #5
S1 (MH “Neoplasms+”)
S2 TX cancer* or malignan* or premalig-
nan* or neoplasm* or carcinoma* or dys-
plasia or tumor* or tumour* or precancer*
S3 S1 or S2
S4 (MH “Larynx+”)
S5 TI laryn* or vocal or glott* or throat or
voice or subglotti* or supraglotti*
S6 S4 or S5
S7 S3 and S6
S8 (MH “Laryngeal Neoplasms”)
S9 S7 or S8
S10 (MH “Radiotherapy+”)
S11 TI irradiat* OR radiotherap* OR ra-
diation
S12 (MH “Surgery, Operative”)
S13 TI surgery OR surgical* OR (laryn*
AND preserv*) OR laryngectom* OR
hemilaryngectom* OR (excision AND
biops*) OR endoscop* OR endolaryngeal
OR transoral* OR (trans AND oral*)OR
(neck AND incision*) OR cordectom*OR
(vocal AND cord AND stripping)
S14 S10 or S11 or S12 or S13
S15 S9 and S14
laryn* AND cancer* OR laryn* AND car-
cinom*OR laryngec*ORglott* ANDcan-
cer* OR glott* AND carcinom* OR voice
AND cancer* OR voice AND carcinom*
OR vocal AND cancer* OR vocal AND
carcinom*
WH A T ’ S N E W
Last assessed as up-to-date: 18 September 2014.
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Date Event Description
20 October 2014 New citation required but conclusions have not
changed
We identified no new studies for inclusion in the re-
view. One study is ongoing (Saedi 2007).
Therewere no changes to the conclusions of the review.
We updated the study quality assessment method to
the Cochrane ’Risk of bias’ tool
We updated the ’Background’, ’Discussion’ and ’Im-
plications for practice and research’ sections to reflect
current clinical practice and the decisions that patients
and practitioners have to make in 2014
18 September 2014 New search has been performed New searches run.
H I S T O R Y
Protocol first published: Issue 2, 2000
Review first published: Issue 2, 2002
Date Event Description
2 June 2010 New search has been performed New searches run 1 October 2009. No new studies were included in the
review. We identified two further ongoing studies
26 October 2008 Amended Converted to new review format.
22 August 2007 New search has been performed New search carried out April 2007. No new studies found. The authors are
now aware of two ongoing studies which may be included in future updates
of this review
25 August 2004 New search has been performed New searches November 2003. No new studies identified.
C O N T R I B U T I O N S O F A U T H O R S
Janet Wilson (previous author), RW and KMacK were responsible for the conception of the review. PD and DA planned the first
electronic search and screened the abstracts. PD, supported by Gemma Sandberg from the Cochrane ENT Group, planned the second
electronic search and PD and KMacK screened the trials. The third and fourth electronic searches were conducted by Carolyn Doree
from the Cochrane ENT group and PD assessed the abstracts. RW and KMacK assessed the trials. All authors discussed the review.
PD extracted data. The first draft of the manuscript was completed by PD. All authors commented on the manuscript and agreed the
final draft. PD updated the review. In 2014 an update was undertaken with searches performed by Gemma Sandberg and Samantha
Faulkner. Laura Warner and Jessal Chudasama screened the results in conjunction with Paola Dey. Laura Warner, Paola Dey and Sean
Loughran updated the text of the review. DA has retired.
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D E C L A R A T I O N S O F I N T E R E S T
KMacK and RW are members of the UK feasibility study comparing the effectiveness of radiotherapy and endoscopic excision (with
or without laser) (EaStER). Laura Warner, Paola Dey, Sean Loughran, Jessal Chudasama and Charles Kelly do not have any known
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S O U R C E S O F S U P P O R T
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• Freeman Hospital Trustees, Newcastle upon Tyne, UK.
External sources
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We updated the assessment of risk of bias in the included studies in 2014 to the Cochrane ’Risk of bias’ method. We separated outcomes
into ’primary’ and ’secondary’ and added information regarding potential future data synthesis.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Carcinoma, Squamous Cell [mortality; pathology; ∗radiotherapy; ∗surgery]; Disease-Free Survival; Glottis [surgery]; Laryngeal Neo-
plasms [mortality; pathology; ∗radiotherapy; ∗surgery]; Laser Therapy; Randomized Controlled Trials as Topic
MeSH check words
Humans
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